Trial · NCT04588792
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Improvement in pulmonary gas exchange | Study Day 6 | Improvement in oxygenation as determined by a standardized PaO2/FiO2 ratio |
| Primary | Requirement for mechanical ventilation | Baseline to day 28 | Number of ventilator-free days in the first 28 days after enrollment |
| Secondary | Mortality | Day 60 post enrollment | All Cause |
| Secondary | Requirement for supplemental oxygen | To day 28 post enrollment | Number of days of alive and not requiring supplemental oxygen |
| Secondary | Duration of ICU Stay | Up to 60 days post enrollment | Duration of ICU Stay |
| Secondary | Length of hospitalization | Up to 60 days post enrollment | Length of hospitalization |
| Secondary | Adverse events | Up to 60 days post enrollment | Incidence of serious adverse events: incorporated as trial outcomes, defined a priori, in accordance with guidelines for academic ICU drug trials |
| Secondary | Inhalation adverse events | Up to day 28 | Adverse events during the nebulization of furosemide |
| Other | Serum levels of furosemide | Up to day 28 | Serum levels of furosemide every 7 days until the completion of therapy |
| Other | Electrolyte abnormalities | Up to day 28 | Altered electrolytes on routine testing (frequency of hypokalemia (\< 3.0 meq/L), hypernatremia (\> 150 meq/L) or increased bicarbonate levels (\>30 meq/L) during the ICU stay |
| Other | Cytokine levels | Up to day 28 | Levels of serum inflammatory cytokines (IL-6, IL-8, TNF-α) at baseline prior to first dose of intervention, day 7, and the completion of therapy |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04588792/registered